The KW18 peptide acts as a dual antimicrobial and immunomodulatory therapeutic candidate in the context of antimicrobial resistance
European Journal of Clinical Microbiology & Infectious Diseases · 2026
DOI: 10.1007/s10096-026-05417-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Clinical Microbiology & Infectious Diseases, 2026. Verfasst von Layza Sá Rocha und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratório de Purificação de Proteínas e suas Funções Biológicas, Universidade Federal do Mato Grosso do Sul, Campo Grande, MS, Brazil. Hauptthemen laut MEDLINE: Immunomodulating Agents, Antimicrobial Peptides, Anti-Infective Agents, Immunologic Factors. Die Arbeit nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidade Federal De Mato Grosso Do Sul.
Abstract (Originalsprache)
PURPOSE: Healthcare-associated infections and antimicrobial resistance present major challenges worldwide, especially for immunocompromised patients. This study aimed to evaluate the antimicrobial, antibiofilm, and immunomodulatory properties of KW18, a synthetic peptide (NH₂-KWIRRIIRRYVCFFRKFI-COOH) designed through bioinformatics to target multidrug-resistant bacteria and fungi, and to determine whether KW18 could serve as a dual-action therapy with potent microbicidal and anti-inflammatory effects. METHODS: KW18 was tested against Gram-positive and Gram-negative bacteria (Staphylococcus aureus, Pseudomonas aeruginosa) and fungi (Candida glabrata, C. tropicalis). MIC and MBC assays, time-kill curves, and checkerboard synergy tests were performed. Its antibiofilm activity was evaluated on mature biofilms. Membrane disruption was assessed using Sytox™ Green and ergosterol-binding assays. Immunomodulatory effects were analyzed in LPS-stimulated BV-2 microglial cells by measuring nitric oxide, IL-6, and IL-10 levels, and cytotoxicity was evaluated with cell viability assays. RESULTS: KW18 exhibited potent antimicrobial activity, with low MIC and MBC values across all strains, and retained antifungal effects even in the presence of ergosterol or sorbitol. Time-kill studies showed rapid, concentration-dependent microbicidal effects. The peptide worked synergistically with ciprofloxacin and amphotericin B, effectively inhibiting and eliminating mature biofilms and, in some cases, outperforming conventional treatments. Mechanistic tests confirmed membrane disruption. In BV-2 cells, KW18 reduced nitric oxide and IL-6 while increasing IL-10, all while maintaining over 85% cell viability, with a lower IC₅₀ for NO suppression than dexamethasone. CONCLUSION: KW18 demonstrates strong antimicrobial, antibiofilm, and immunomodulatory activities, supporting its potential as a promising dual-function therapeutic candidate for resistant infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratório de Purificação de Proteínas e suas Funções Biológicas, Universidade Federal do Mato Grosso do Sul, Campo Grande, MS, Brazil.
- Laboratório de RMN, Universidade Federal de Goiás, Goiânia, GO, Brasil.
- Programa de Pós-Graduação em Biotecnologia, S-Inova Biotech, Universidade Católica Dom Bosco, Campo Grande - MS, Campo Grande, MS, Brazil.
- Centro de Análises Proteômicas e Bioquímicas, Programa de Pós-graduação em Ciências Genômicas e Biotecnologia, Universidade Católica de Brasília, Brasília, DF, Brazil.
- Programa de Pós-Graduação em Ciências Ambientais e Sustentabilidade Agropecuária, Universidade Católica Dom Bosco, Campo Grande, MS, Brazil.
- Laboratório de Purificação de Proteínas e suas Funções Biológicas, Universidade Federal do Mato Grosso do Sul, Campo Grande, MS, Brazil. ligiamacedo18@gmail.com.
Förderung
- Universidade Federal De Mato Grosso Do Sul
Zitieren
APA
Rocha, L. S., Jacobowski, A. C., Thiburcio, E., de Araújo Boleti, A. P., Matos, C. O., Barra, J. B., Lião, L. M., Buccini, D. F., Franco, O. L., Cardoso, M. H., & Macedo, M. L. R. (2026). The KW18 peptide acts as a dual antimicrobial and immunomodulatory therapeutic candidate in the context of antimicrobial resistance. European Journal of Clinical Microbiology & Infectious Diseases. https://doi.org/10.1007/s10096-026-05417-4
Vancouver
Rocha LS, Jacobowski AC, Thiburcio E, de Araújo Boleti AP, Matos CO, Barra JB, et al. The KW18 peptide acts as a dual antimicrobial and immunomodulatory therapeutic candidate in the context of antimicrobial resistance. European Journal of Clinical Microbiology & Infectious Diseases. 2026. doi:10.1007/s10096-026-05417-4
BibTeX
@article{Rocha2026,
author = {Rocha, Layza Sá and Jacobowski, Ana Cristina and Thiburcio, Eduarda and de Araújo Boleti, Ana Paula and Matos, Carolina Oliveira and Barra, Juliana Bueno and Lião, Luciano Morais and Buccini, Danieli Fernanda and Franco, Octávio Luiz and Cardoso, Marlon Henrique and Macedo, Maria Ligia Rodrigues},
title = {The KW18 peptide acts as a dual antimicrobial and immunomodulatory therapeutic candidate in the context of antimicrobial resistance},
journal = {European Journal of Clinical Microbiology & Infectious Diseases},
year = {2026},
doi = {10.1007/s10096-026-05417-4}
}
EUVIMED